Clinical trial
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
NCT04632225 is registered in ClinicalTrials.gov with Helixmith Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
- Lead sponsor
- Helixmith Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 9, 2021
- Completion date
- July 15, 2024
- Enrollment
- 18 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.